$CAH

Cardinal Health makes acquisition duo worth $360m for home care business advance

Cardinal Health said it will buy Strive Medical and AdaptHealth’s diabetes business in a combined $360m deal to expand its at-home solutions. The company noted prior diabetes acquisition of Advanced Diabetes Supply in April 2025 and recent urology buys. Cardinal cited operational progress since ADS closing, including migrating volume, adding about 500,000 customers, and launching ContinuCare Pathway.

Original reporting
Published Jul 21, 2026, 4:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 5:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cardinal Health makes acquisition duo worth $360m for home care business advance — source image
Decision brief

The 30-second read

$CAHBullishMed
01

Why it matters

The new acquisitions add diabetes and urology capabilities and expand distribution and customer onboarding momentum already cited from ADS integration.

02

Market read

A $360m acquisition duo is a concrete M&A catalyst that can re-rate Cardinal’s home-care growth profile, subject to integration and deal economics.

03

What to watch

No details on purchase price allocation, expected synergies, or financing structure are provided, which are key drivers of post-deal valuation.

Relevance 8/10Novelty 7/10Timing: deal announcement, positioned for near-term M&A/integration positioning

Background

Cardinal is building its at-home solutions platform via prior acquisitions, including Advanced Diabetes Supply (ADS) in April 2025 and multiple urology-related buys in 2025.

Company-level read

Ticker impact

$CAHBullishMedium confidence
Context

Cardinal Health announced a $360m acquisition duo, buying Strive Medical and AdaptHealth's diabetes unit to expand at-home care services.

Expected impact

Moderately positive bias, with volatility tied to deal integration and funding/valuation assumptions.

Evidence & confidence

The article discloses the transaction size ($360m) and the strategic rationale (at-home solutions depth in diabetes and urology), but provides no financing terms or guidance impact.

Market effects

Reinforces consolidation in home-care and specialty medical supplies, potentially increasing competitive pressure on smaller home-care distributors.

US-focused at-home solutions expansion may shift demand within domestic distribution networks.

Limited direct global impact; primarily US healthcare services and supply-chain dynamics.

Counterpoint

The headline deal value may not translate into durable margin expansion if integration costs or reimbursement dynamics pressure returns.

Key entities

  • Cardinal Health

    US drug and medical supplies distributor expanding its at-home solutions business via acquisitions.

  • Strive Medical

    Urology-focused medical supplier being acquired by Cardinal as part of the $360m duo.

  • AdaptHealth

    Cardinal is acquiring AdaptHealth's diabetes business unit as part of the $360m duo.

Related articles

$CAHMedAI 9/10

Cardinal Health to buy AdaptHealth diabetes unit, Strive Medical for $360 million By Reuters

Cardinal Health (CAH) agreed to buy AdaptHealth’s diabetes health business for $235 million cash and to acquire Strive Medical in a separate deal, for about $360 million total, to expand its at-Home Solutions and diabetes care. Cardinal said the deals should add to adjusted EPS within 12 months after closing. AdaptHealth and Strive Medical described their diabetes and urology-focused services.

$CAHMedAI 8/10

Cardinal Health expands home care business with two tuck-in acquisitions

Cardinal Health (NYSE: CAH) said it agreed to buy AdaptHealth’s Diabetes Health business and acquire Strive Medical, expanding its at-Home Solutions unit. The deals total about $360 million in cash, subject to working capital adjustments, and are expected to be accretive to non-GAAP EPS in the first 12 months after closing. Closing depends on regulatory approvals.

$METAMed

It's a jam-packed afternoon of developments impacting 7 portfolio stocks

CNBC’s Investing Club said stocks rose Thursday as investors discounted U.S.-Iran escalation. Meta shares swung after Reuters reported plans to expand AI compute and release Muse Park 1.1 with an API. Cowen raised Cardinal Health’s target to $275. FedEx launched Life Sciences. Reuters said Honeywell may add Europe defense products. Starbucks rose on Bloomberg AI software plans.

$CAHMed

Cardinal Health Stock: Is CAH Outperforming the Healthcare Sector?

Cardinal Health (CAH), a Dublin, Ohio healthcare distributor and solutions provider, reported Q3 fiscal 2026 revenue up 11% to $60.90B and non-GAAP operating earnings up 18% to $956M. Non-GAAP EPS rose 35% to $3.17. The company raised fiscal 2026 non-GAAP EPS guidance to $10.70–$10.80. CAH shares have outperformed peers and analysts rate it “Strong Buy” with a $247.47 mean target.